Recurrent and pathological gene fusions in breast cancer: current advances in genomic discovery and clinical implications
- 2 July 2016
- journal article
- review article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 158 (2), 219-232
- https://doi.org/10.1007/s10549-016-3876-y
Abstract
Gene fusions have long been considered principally as the oncogenic events of hematologic malignancies, but have recently gained wide attention in solid tumors due to several milestone discoveries and the advancement of deep sequencing technologies. With the progress in deep sequencing studies of breast cancer transcriptomes and genomes, the discovery of recurrent and pathological gene fusions in breast cancer is on the focus. Recently, driven by new deep sequencing studies, several recurrent or pathological gene fusions have been identified in breast cancer, including ESR1-CCDC170, SEC16A-NOTCH1, SEC22B-NOTCH2, and ESR1-YAP1 etc. More important, most of these gene fusions are preferentially identified in the more aggressive breast cancers, such as luminal B, basal-like, or endocrine-resistant breast cancer, suggesting recurrent gene fusions as additional key driver events in these tumors other than the known drivers such as the estrogen receptor. In this paper, we have comprehensively summarized the newly identified recurrent or pathological gene fusion events in breast cancer, reviewed the contributions of new genomic and deep sequencing technologies to new fusion discovery and the integrative bioinformatics tools to analyze these data, highlighted the biological relevance and clinical implications of these fusion discoveries, and discussed future directions of gene fusion research in breast cancer.Keywords
Funding Information
- Congressionally Directed Medical Research Programs (W81XWH-13-1-0431)
- National Cancer Institute (1R01CA181368, 1R01CA183976)
- Commonwealth of PA Tobacco Phase 15 Formula Fund
This publication has 82 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancerNature Medicine, 2011
- Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practiceAnnals of Oncology, 2011
- Genome-wide association study identifies five new breast cancer susceptibility lociNature Genetics, 2010
- Complex landscapes of somatic rearrangement in human breast cancer genomesNature, 2009
- An integrative approach to reveal driver gene fusions from paired-end sequencing data in cancerNature Biotechnology, 2009
- EML4–ALK fusion transcript is not found in gastrointestinal and breast cancersBritish Journal of Cancer, 2008
- ETV6-NTRK3 Fusion Oncogene Initiates Breast Cancer from Committed Mammary Progenitors via Activation of AP1 ComplexCancer Cell, 2007
- The impact of translocations and gene fusions on cancer causationNature Reviews Cancer, 2007
- A census of human cancer genesNature Reviews Cancer, 2004